203 related articles for article (PubMed ID: 33048886)
1. Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
Kohli M; Moore DJ; Moore RC
AIDS; 2021 Jan; 35(1):15-22. PubMed ID: 33048886
[No Abstract] [Full Text] [Related]
2. Cognitive impairment in people with HIV: one step closer to criteria that capture neurocognitive diversity.
Filip I
AIDS; 2023 Nov; 37(13):N15-N16. PubMed ID: 37755424
[No Abstract] [Full Text] [Related]
3. Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?
Brew BJ; Clifford DB
AIDS; 2023 Nov; 37(13):2095-2096. PubMed ID: 37755427
[No Abstract] [Full Text] [Related]
4. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
[TBL] [Abstract][Full Text] [Related]
5. Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
Brew BJ
AIDS; 2016 Sep; 30(15):2379-80. PubMed ID: 27603161
[No Abstract] [Full Text] [Related]
6. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
7. Organic mental disorders in HIV-1 infection.
Maj M
AIDS; 1990 Sep; 4(9):831-40. PubMed ID: 2252558
[No Abstract] [Full Text] [Related]
8. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.
Robbins RN; Scott TM; Gouse H; Marcotte TD; Rourke SB
Curr Top Behav Neurosci; 2021; 50():429-478. PubMed ID: 32677005
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated neurocognitive disorders: still a hot topic?
Levy I
Isr Med Assoc J; 2015 Jan; 17(1):52-3. PubMed ID: 25739179
[No Abstract] [Full Text] [Related]
10. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
Nyundo AA
PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
[TBL] [Abstract][Full Text] [Related]
11. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
Watson CW; Paolillo EW; Morgan EE; Umlauf A; Sundermann EE; Ellis RJ; Letendre S; Marcotte TD; Heaton RK; Grant I
J Acquir Immune Defic Syndr; 2020 Jan; 83(1):56-64. PubMed ID: 31809361
[TBL] [Abstract][Full Text] [Related]
12. Screening HIV associated neurocognitive disorders using international HIV dementia scale: closing the gap through an educational intervention for healthcare workers.
Namagga JK; Nambozi G; Rukundo GZ; Niyonzima V; Batwala V
Pan Afr Med J; 2023; 44():17. PubMed ID: 37013204
[TBL] [Abstract][Full Text] [Related]
13. HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
Vance DE; Brew BJ
AIDS; 2021 Mar; 35(3):511-513. PubMed ID: 33507007
[No Abstract] [Full Text] [Related]
14. Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy.
Focà E; Magro P; Motta D; Compostella S; Casari S; Bonito A; Brianese N; Ferraresi A; Rodari P; Pezzoli MC; Quiros-Roldan E; Castelli F
Int J Mol Sci; 2016 Mar; 17(4):434. PubMed ID: 27023519
[TBL] [Abstract][Full Text] [Related]
15. Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.
Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA
AIDS Behav; 2021 Mar; 25(3):917-960. PubMed ID: 33025390
[TBL] [Abstract][Full Text] [Related]
16. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.
Namagga JK; Rukundo GZ; Voss JG
J Assoc Nurses AIDS Care; 2019; 30(5):531-538. PubMed ID: 31461736
[TBL] [Abstract][Full Text] [Related]
18. Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
Force G; Ghout I; Ropers J; Carcelain G; Marigot-Outtandy D; Hahn V; Darchy N; Defferriere H; Bouaziz-Amar E; Carlier R; Dorgham K; Callebert J; Peytavin G; Delaugerre C; de Truchis P;
J Antimicrob Chemother; 2021 Feb; 76(3):743-752. PubMed ID: 33179033
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
